» Articles » PMID: 28892501

Implementation of a Study to Examine the Persistence of Ebola Virus in the Body Fluids of Ebola Virus Disease Survivors in Sierra Leone: Methodology and Lessons Learned

Abstract

Background: The 2013-2016 West African Ebola virus disease epidemic was unprecedented in terms of the number of cases and survivors. Prior to this epidemic there was limited data available on the persistence of Ebola virus in survivors' body fluids and the potential risk of transmission, including sexual transmission.

Methodology/principal Findings: Given the urgent need to determine the persistence of Ebola virus in survivors' body fluids, an observational cohort study was designed and implemented during the epidemic response operation in Sierra Leone. This publication describes study implementation methodology and the key lessons learned. Challenges encountered during implementation included unforeseen duration of follow-up, complexity of interpreting and communicating laboratory results to survivors, and the urgency of translating research findings into public health practice. Strong community engagement helped rapidly implement the study during the epidemic. The study was conducted in two phases. The first phase was initiated within five months of initial protocol discussions and assessed persistence of Ebola virus in semen of 100 adult men. The second phase assessed the persistence of virus in multiple body fluids (semen or vaginal fluid, menstrual blood, breast milk, and urine, rectal fluid, sweat, saliva, tears), of 120 men and 120 women.

Conclusion/significance: Data from this study informed national and global guidelines in real time and demonstrated the need to implement semen testing programs among Ebola virus disease survivors. The lessons learned and study tools developed accelerated the implementation of such programs in Ebola virus disease affected countries, and also informed studies examining persistence of Zika virus. Research is a vital component of the public health response to an epidemic of a poorly characterized disease. Adequate resources should be rapidly made available to answer critical research questions, in order to better inform response efforts.

Citing Articles

Statistical methodologies for evaluation of the rate of persistence of Ebola virus in semen of male survivors in Sierra Leone.

Habib N, Hughes M, Broutet N, Thorson A, Gaillard P, Landoulsi S PLoS One. 2022; 17(10):e0274755.

PMID: 36197875 PMC: 9534448. DOI: 10.1371/journal.pone.0274755.


Persistence of Ebola virus in semen among Ebola virus disease survivors in Sierra Leone: A cohort study of frequency, duration, and risk factors.

Thorson A, Deen G, Bernstein K, Liu W, Yamba F, Habib N PLoS Med. 2021; 18(2):e1003273.

PMID: 33566817 PMC: 7875361. DOI: 10.1371/journal.pmed.1003273.


Presence of Ebola virus in breast milk and risk of mother-to-child transmission: synthesis of evidence.

Medina-Rivera M, Centeno-Tablante E, Finkelstein J, Rayco-Solon P, Pena-Rosas J, Garcia-Casal M Ann N Y Acad Sci. 2020; 1488(1):33-43.

PMID: 33113592 PMC: 8048832. DOI: 10.1111/nyas.14519.


Impact of the Ebola virus disease outbreak (2014-2016) on tuberculosis surveillance activities by Guinea's National Tuberculosis Control Program: a time series analysis.

Magassouba A, Diallo B, Camara L, Sow K, Camara S, Bah B BMC Public Health. 2020; 20(1):1200.

PMID: 32753044 PMC: 7405363. DOI: 10.1186/s12889-020-09230-2.


Perceptions on the collection of body fluids for research on persistence of Ebola virus: A qualitative study.

Kutalek R, Baingana F, Sevalie S, Broutet N, Thorson A PLoS Negl Trop Dis. 2020; 14(5):e0008327.

PMID: 32407312 PMC: 7252625. DOI: 10.1371/journal.pntd.0008327.


References
1.
Pasquier C, Bujan L, Daudin M, Righi L, Berges L, Thauvin L . Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV. J Med Virol. 2003; 69(3):344-9. DOI: 10.1002/jmv.10295. View

2.
Ferraretto X, Estellat C, Damond F, Longuet P, Epelboin S, Demailly P . Timing of intermittent seminal HIV-1 RNA shedding in patients with undetectable plasma viral load under combination antiretroviral therapy. PLoS One. 2014; 9(3):e88922. PMC: 3940424. DOI: 10.1371/journal.pone.0088922. View

3.
Ghosn J, Leruez-Ville M, Blanche J, Delobelle A, Beaudoux C, Mascard L . HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens. Clin Infect Dis. 2014; 58(12):1763-70. DOI: 10.1093/cid/ciu187. View

4.
Arwady M, Garcia E, Wollor B, Mabande L, Reaves E, Montgomery J . Reintegration of ebola survivors into their communities - Firestone District, Liberia, 2014. MMWR Morb Mortal Wkly Rep. 2014; 63(50):1207-9. PMC: 5779529. View

5.
Spengler J, McElroy A, Harmon J, Stroher U, Nichol S, Spiropoulou C . Relationship Between Ebola Virus Real-Time Quantitative Polymerase Chain Reaction-Based Threshold Cycle Value and Virus Isolation From Human Plasma. J Infect Dis. 2015; 212 Suppl 2:S346-9. PMC: 4675930. DOI: 10.1093/infdis/jiv187. View